RCMNY
Rubric Capital Management (New York)’s Collegium Pharmaceutical COLL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.4M | Buy |
3,157,743
+157,743
| +5% | +$4.66M | 1.41% | 19 |
|
|
2025
Q1 | $89.6M | Buy |
3,000,000
+650,000
| +28% | +$19.4M | 1.6% | 19 |
|
|
2024
Q4 | $67.3M | Buy |
2,350,000
+1,100,000
| +88% | +$31.5M | 0.86% | 21 |
|
|
2024
Q3 | $48.3M | Sell |
1,250,000
-1,083,500
| -46% | -$41.9M | 0.79% | 35 |
|
|
2024
Q2 | $75.1M | Buy |
2,333,500
+499,473
| +27% | +$16.1M | 1.97% | 14 |
|
|
2024
Q1 | $71.2M | Sell |
1,834,027
-924,226
| -34% | -$35.9M | 2.1% | 15 |
|
|
2023
Q4 | $84.9M | Sell |
2,758,253
-416,747
| -13% | -$12.8M | 1.76% | 7 |
|
|
2023
Q3 | $71M | Sell |
3,175,000
-250,000
| -7% | -$5.59M | 2.66% | 10 |
|
|
2023
Q2 | $73.6M | Buy |
3,425,000
+150,832
| +5% | +$3.24M | 3.15% | 10 |
|
|
2023
Q1 | $78.5M | Sell |
3,274,168
-59,460
| -2% | -$1.43M | 2.04% | 10 |
|
|
2022
Q4 | $77.3M | Hold |
3,333,628
| – | – | 3.37% | 5 |
|
|
2022
Q3 | $53.4M | Buy |
3,333,628
+75,000
| +2% | +$1.2M | 2.69% | 13 |
|
|
2022
Q2 | $57.7M | Buy |
3,258,628
+258,628
| +9% | +$4.58M | 3.03% | 9 |
|
|
2022
Q1 | $61.1M | Buy |
3,000,000
+393,500
| +15% | +$8.01M | 2.21% | 10 |
|
|
2021
Q4 | $48.7M | Hold |
2,606,500
| – | – | 2.3% | 17 |
|
|
2021
Q3 | $51.5M | Buy |
2,606,500
+186,286
| +8% | +$3.68M | 1.44% | 11 |
|
|
2021
Q2 | $57.2M | Hold |
2,420,214
| – | – | 3.6% | 6 |
|
|
2021
Q1 | $57.4M | Buy |
2,420,214
+493,931
| +26% | +$11.7M | 3.35% | 3 |
|
|
2020
Q4 | $38.6M | Hold |
1,926,283
| – | – | 2.83% | 12 |
|
|
2020
Q3 | $40.1M | Hold |
1,926,283
| – | – | 3.74% | 4 |
|
|
2020
Q2 | $33.7M | Buy |
1,926,283
+712,871
| +59% | +$12.5M | 3.88% | 4 |
|
|
2020
Q1 | $19.8M | Buy |
+1,213,412
| New | +$19.8M | 3.13% | 15 |
|